High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia.

Blood Adv · 2022 · PMC8791566 · PMID 34670275

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

A limitation of our study is the relatively small number of patients, which makes subgroup comparisons less likely to be significant.

also in 1,824 other papers

showed a trendno p-value reported

Development of T/NK lymphoma showed a trend with increased mortality.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.